Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiraLAX for Occasional Constipation
NCT00770432Phase 4Completed
- Sponsor
- Bayer
- Start
- Nov 2007
- Primary completion
- Jan 2008
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
01
Overview
A Phase 4 trial of polyethylene glycol 3350 in constipation, sponsored by Bayer. Started Nov 2007; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
constipation
Beyond the preview
Go deeper on NCT00770432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770432.